Abstract
Cardiac hypertrophy, interstitial fibrosis, and cardiac dysfunction ultimately lead to cardiac failure. Cardiac failure is one of the major causes of heart disease and death in our society. The molecular causes of heart diseases, like many other diseases, remain largely unknown. Recently, large-scale proteomics studies have been undertaken to better understand the underlying mechanisms of molecular causes of heart disease. Many protein alterations have already been identified in the human diseased myocardium. Further experiments on these proteins are ongoing to know their suitability for drug targets, therapeutic proteins, or disease biomarkers. This review deals with a proteomics perspective on human heart failure, and is divided into two parts. The first part provides a glimpse on proteomics technologies used for identification and quantification of proteins related to heart disease. The second part is the main focus of this review and deals with evolving biomarkers and clinical diagnostics, potential future drugs, clinical approaches in managing heart failure, and clinical shortcomings, which are discussed to some detail from the viewpoint of a medical doctor and proteomics scientists.
Keywords: Cardiac proteomics, human disease, two-dimensional gel electrophoresis, mass spectrometry, biomarkers, review
Current Proteomics
Title: Human Heart Failure: A Proteomics Perspective
Volume: 4 Issue: 3
Author(s): Arvind Goel, Randeep Rakwal and Ganesh Kumar Agrawal
Affiliation:
Keywords: Cardiac proteomics, human disease, two-dimensional gel electrophoresis, mass spectrometry, biomarkers, review
Abstract: Cardiac hypertrophy, interstitial fibrosis, and cardiac dysfunction ultimately lead to cardiac failure. Cardiac failure is one of the major causes of heart disease and death in our society. The molecular causes of heart diseases, like many other diseases, remain largely unknown. Recently, large-scale proteomics studies have been undertaken to better understand the underlying mechanisms of molecular causes of heart disease. Many protein alterations have already been identified in the human diseased myocardium. Further experiments on these proteins are ongoing to know their suitability for drug targets, therapeutic proteins, or disease biomarkers. This review deals with a proteomics perspective on human heart failure, and is divided into two parts. The first part provides a glimpse on proteomics technologies used for identification and quantification of proteins related to heart disease. The second part is the main focus of this review and deals with evolving biomarkers and clinical diagnostics, potential future drugs, clinical approaches in managing heart failure, and clinical shortcomings, which are discussed to some detail from the viewpoint of a medical doctor and proteomics scientists.
Export Options
About this article
Cite this article as:
Goel Arvind, Rakwal Randeep and Agrawal Kumar Ganesh, Human Heart Failure: A Proteomics Perspective, Current Proteomics 2007; 4 (3) . https://dx.doi.org/10.2174/157016407783221303
DOI https://dx.doi.org/10.2174/157016407783221303 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
Call for Papers in Thematic Issues
Mass spectrometry data acquisition and analysis for proteomics
The Thematic Issue on "Mass spectrometry data acquisition and analysis for proteomics" aims to explore the latest advancements and challenges in the field of proteomics through the lens of mass spectrometry. Proteomics, the large-scale study of proteins and their functions, plays a crucial role in understanding various biological processes and ...read more
Peptides: State-of-Art and Commercialisation Hurdles
The Editors of the Current Proteomics (CP) journal are highly privileged to welcome scientists to submit their scientific research and review articles to be considered for publication in the upcoming thematic issue. The topics should cover various aspects of peptides in regard to their synthetic methodologies, formulation approaches, pharmacological challenges, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Advances in the Chemistry of Saccharins: From Synthetic Novelties Towards Biologically Active Compounds
Current Medicinal Chemistry Vulnerable Plaque and Inflammation: Potential Clinical Strategies
Current Pharmaceutical Design Interaction Between Platelets and Cytokines - A Possible Role in the Pathogenesis of Preeclampsia
Vascular Disease Prevention (Discontinued) HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol
Current Drug Targets - Cardiovascular & Hematological Disorders Antioxidant and Antimicrobial Activities of Cinnamic Acid Derivatives
Mini-Reviews in Medicinal Chemistry Encapsulation of Plant-derived Bioactive Ingredients through Electrospraying for Nutraceuticals and Functional Foods Applications
Current Medicinal Chemistry Coronary Atherosclerotic Disease Burden: An Emerging Endpoint in Progression / Regression Studies Using Intravascular Ultrasound
Current Drug Targets - Cardiovascular & Hematological Disorders Modulation of Neutrophil Function by Hormones
Current Immunology Reviews (Discontinued) TNF-α and IL-8 in Acute Stroke and the Modulation of these Cytokines by Antiplatelet Agents
Current Neurovascular Research Vascular Inflammation and Atherosclerosis: The Role of Estrogen Receptors
Current Medicinal Chemistry Exosomes: Structure, Biogenesis, Types and Application in Diagnosis and Gene and Drug Delivery
Current Gene Therapy Management of Obesity
Current Respiratory Medicine Reviews Non Alcoholic Fatty Liver: Epidemiology and Natural History
Reviews on Recent Clinical Trials Alternatively Spliced Genes as Biomarkers for Schizophrenia, Bipolar Disorder and Psychosis: A Blood-Based Spliceome-Profiling Exploratory Study (Supplementry Table)
Current Pharmacogenomics and Personalized Medicine Strategies for Integral Metabolism Profile of Multiple Compounds in Herbal Medicines: Pharmacokinetics, Metabolites Characterization and Metabolic Interactions
Current Drug Metabolism Dendritic Cells: A Double-Edge Sword in Atherosclerotic Inflammation
Current Pharmaceutical Design Biological Therapies For Inflammatory Bowel Disease: Research DrivesClinics
Mini-Reviews in Medicinal Chemistry Editorial (Thematic Issue: Novel Data on the Pathogenesis of Atherosclerosis, Treatment Targets, and New Therapeutic Interventions in Lipid-Related Cardiovascular Risk Factors)
Current Pharmaceutical Design ErbB4 and its Isoforms: Patentable Drug Targets?
Recent Patents on DNA & Gene Sequences Recent Advances in the Synthesis of Biologically Active Cinnoline, Phthalazine and Quinoxaline Derivatives
Current Organic Chemistry